Prospective Evaluation of Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusion Requirements

What this Trial Is About

Researchers are conducting a prospective observational study to understand how robot-assisted surgical treatment for radical cystectomy and possible bladder reconstruction affects blood loss, pain, and the need for blood transfusions. This study takes place at a tertiary center and aims to compare robot-assisted laparoscopic cystectomy with conventional laparotomy. It focuses on patients who are planned for radical cystectomy and evaluates important surgical outcomes. Participants will undergo one of two surgical approaches: robot-assisted laparoscopic cystectomy or conventional open surgery through laparotomy. The study will measure blood loss during the perioperative period, specifically within six hours of surgery. It will also assess preoperative iron deficiency up to four weeks before surgery and monitor red blood cell transfusions from the perioperative period up to hospital discharge or death, which may occur up to four weeks after surgery. During the study, participants will be closely observed for blood loss, pain levels, and transfusion requirements. Researchers will collect data on surgical outcomes and patient conditions before and after surgery. The study starts in August 2025 and will continue through December 2027. Participants will be monitored throughout their hospital stay and up to four weeks after surgery to gather comprehensive information on these key measures.

Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.